<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99244">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02045758</url>
  </required_header>
  <id_info>
    <org_study_id>14-P002</org_study_id>
    <nct_id>NCT02045758</nct_id>
  </id_info>
  <brief_title>A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick</brief_title>
  <official_title>A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick Using the SAFE-T-FILL Capillary Blood Collection System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seventh Sense Biosystems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seventh Sense Biosystems</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare blood collection from the forearm using an investigational device
      TAP20-C to blood collection from the fingertip.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Non-Inferiority of Analyte Levels</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>The study will compare the concentrations of various analytes in blood samples collected by both collection methods in a single 2 hour session.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>TAP20-C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAP20-C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAFE-T-FILL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SAFE-T-FILL</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SAFE-T-FILL</intervention_name>
    <arm_group_label>SAFE-T-FILL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAP20-C</intervention_name>
    <arm_group_label>TAP20-C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Subject Group

               1. Male and female volunteers 18 years of age or older.

               2. Voluntary written consent to participate in this study. Diabetic Subject Group

               1. Male and female volunteers 18 years of age or older.

               2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report.

               3. Voluntary written consent to participate in this study.

        Exclusion Criteria:

          1. Subjects who are pregnant or nursing mothers by self-report.

          2. Subjects who have eaten or consumed sugar-containing drinks in the 2 hours prior to
             arrival at the study site on the testing daybefore blood sample collection begins.

          3. Subjects with a history of skin disorders or who present with abnormal skin integrity
             or atypical skin health within the areas to be tested.

          4. Subjects with a missing index or middle finger on either hand or a missing forearm

          5. Subjects who have known allergies to titanium.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Howard Bernstein, MD, Phd</last_name>
    <phone>617-547-7246</phone>
    <email>hbernstein@7sbio.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seventh Sense Biosystems</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 15, 2014</lastchanged_date>
  <firstreceived_date>January 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
